ALN-4915 Investigational RNAi candidate in Phase 1 studies involving healthy volunteers, with its intended disease indication undisclosed in Alnylam’s current public pipeline.
Visit productCosigns Received
Be the first Cosign
Put your name behind ALN-4915.
Add it to your Products I use list and share why you use it.